Purpose To develop methods for creating pseudo-contrast-enhanced US (CEUS) by using an enhanced generative adversarial network and evaluate its ability to assess tumor ablation effectiveness. Materials and Methods This retrospective study included 1030 patients who underwent thyroid nodule ablation across seven centers from January 2020 to April 2023. A generative adversarial network-based model was developed for direct pseudo-CEUS generation from B-mode US and tested on thyroid, breast, and liver ablation datasets. The reliability of pseudo-CEUS was assessed using structural similarity index (SSIM), color histogram correlation, and mean absolute percentage error against real CEUS. Additionally, a subjective evaluation system was devised to validate its clinical value. The Wilcoxon signed rank test was employed to analyze differences in the data. Results The study included 1030 patients (mean age, 46.9 years ± 12.5 [SD]
799 female and 231 male patients). For internal test set 1, the mean SSIM was 0.89 ± 0.05, while across external test sets 1-6, mean SSIM values ranged from 0.84 ± 0.08 to 0.88 ± 0.04. Subjective assessments affirmed the method's stability and near-realistic performance in evaluating ablation effectiveness. The thyroid ablation datasets had an average identification score of 0.49 (0.5 indicates indistinguishability), while the similarity average score for all datasets was 4.75 out of 5. Radiologists' assessments of residual blood supply were nearly consistent, with no differences in defining ablation zones between real and pseudo-CEUS. Conclusion The pseudo-CEUS method demonstrated high similarity to real CEUS in evaluating tumor ablation effectiveness.